GCGolam Azam Chowdhury

Golam Azam Chowdhury

*This is an algorithmically generated author record based on publicly available information.

Golam Azam Chowdhury has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Molecular characterisation of foot-and-mouth disease viruses collected from Bangladesh during 2021–23: evidence for trans-pool spread of exotic viral lineages

    by Hyeonjeong Kang, Soyoon Ryoo, Da-Rae Lim, Tae-Yoon Eom, Jae-Myung Kim, Jongwan Kim, Shukes Chandra Badhy, Mohammad Sadekuzzaman, Shamima Akter, Antonello Di Nardo, et al.

    Foot-and-mouth disease (FMD) remains endemic in Bangladesh with the persistent circulation of FMD virus (FMDV) serotypes O, A, and Asia 1, underscoring the need for robust epidemiological data to inform and optimize national FMD control strategies. This study analyzed 57 VP1 coding sequences obtained from 89 clinical samples collected from FMD-infected cattle in Bangladesh between 2021 and 2023. Phylogenetic analysis classified these field isolates into three FMDV lineages: O/ME-SA/Ind-2001e ( n = 40, 70.2%), O/ME-SA/SA-2018 ( n = 15, 26.3%), and A/ASIA/Iran-05 ( n = 2, 3.5%). The O/ME-SA/SA-2018 lineage detected in 2022 (61.1%) and 2023 (25.0%) shared 94.24–99.06% nucleotide sequence identity with viruses from the same lineage collected in 2021. Sequences for O/ME-SA/SA-2018 were monophyletic, while data for O/ME-SA/Ind-2001e provided evidence for viruses evolving within two sister clades in Bangladesh during 2021–23. Additionally, two samples collected in 2023 and tested positive for serotype A were characterized as belonging to the A/ASIA/Iran-05 lineage (sublineage FAR-11), representing the first cases of this lineage reported within the FMD endemic Pool 2. Analyses showed that VP1 sequences for two isolates (A/BAN5/2023 and A/BAN6/2023) were most closely related to a virus isolated in Pakistan during 2022 (PAK/41/2022a), sharing 97.81% nucleotide identity and a common ancestor dated March 2022. Further studies are needed to identify likely pathways of introduction of the A/Iran-05 lineage in Bangladesh, as well as to assess the potential risk to neighboring countries. This study highlights the importance of continuous FMD monitoring in Bangladesh to inform both control and vaccination strategies.


  • Open Access

    Integrating Serological and Genomic Data to Elucidate Lumpy Skin Disease Virus Diversity in Cattle from Bangladesh

    by Nasrin Sultana Tonu, Sajedul Hayat, Shukes Chandra Badhy, Salima Ferdows, Golam Azam Chowdhury, Babu Kanti Nath, Safiul Alam Bhuiyan, Muhammad Jasim Uddin, Suman Das Gupta, Subir Sarker

    Lumpy skin disease virus (LSDV), a transboundary pathogen threatening cattle health in South and Southeast Asia, presents growing challenges for disease control. This study combined serological, molecular, and genomic approaches to investigate LSDV in Barura Upazila, Bangladesh. Serological screening of 424 cattle using a commercial ELISA revealed a high seroprevalence of 55.5% (95% CI: 50.7–60.3), indicating widespread exposure. Although differences were observed by age and breed, no significant associations were found with seropositivity, suggesting broad regional circulation. Real-time PCR confirmed LSDV DNA in all 20 clinically infected animals, with consistent P32 gene amplification. Two samples with low Cq values underwent whole-genome sequencing. The complete genomes of LSDV-L2/2024 and LSDV-L3/2024 showed >99.6% identity with the reference strain LSDV-29, yet carried unique genomic features, including truncated or variant ORFs and immune-related gene differences. Phylogenetic analysis of the DNA polymerase gene revealed distinct clustering: L2/2024 aligned with South Asian isolates, while L3/2024 grouped with strains from Africa, the Middle East, and Europe. These results highlight co-circulation of genetically diverse strains and possible cross-regional introductions. Overall, our findings underscore the evolutionary plasticity of LSDV and the critical need for ongoing genomic surveillance to guide targeted vaccine development and disease control strategies.